These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 36246978)

  • 1. Systematic Analysis of CXC Chemokine-Vascular Endothelial Growth Factor A Network in Colonic Adenocarcinoma from the Perspective of Angiogenesis.
    Situ Y; Lu X; Cui Y; Xu Q; Deng L; Lin H; Shao Z; Chen J
    Biomed Res Int; 2022; 2022():5137301. PubMed ID: 36246978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines.
    Sun X; Chen Q; Zhang L; Chen J; Zhang X
    Math Biosci Eng; 2021 Jul; 18(5):6262-6287. PubMed ID: 34517533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. System analysis of
    Situ Y; Xu Q; Deng L; Zhu Y; Gao R; Lei L; Shao Z
    Int J Biol Markers; 2022 Mar; 37(1):90-101. PubMed ID: 34870494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated expression of CXCL3 in colon cancer promotes malignant behaviors of tumor cells in an ERK-dependent manner.
    Cheng Y; Yang X; Liang L; Xin H; Dong X; Li W; Li J; Guo X; Li Y; He J; Zhang C; Wang W
    BMC Cancer; 2023 Nov; 23(1):1162. PubMed ID: 38031087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the Prognosis and Therapeutic Value of the CXC Chemokine Family in Head and Neck Squamous Cell Carcinoma.
    Li Y; Wu T; Gong S; Zhou H; Yu L; Liang M; Shi R; Wu Z; Zhang J; Li S
    Front Oncol; 2020; 10():570736. PubMed ID: 33489879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma.
    Huang J; Chen Z; Ding C; Lin S; Wan D; Ren K
    Front Oncol; 2021; 11():711402. PubMed ID: 34497764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of therapeutic targets and prognostic biomarkers among CXC chemokines in hepatocellular carcinoma microenvironment.
    Yin Z; Ma T; Chen S; Yu M
    Cancer Biomark; 2023; 36(3):231-250. PubMed ID: 36938723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment.
    Zhou X; Peng M; He Y; Peng J; Zhang X; Wang C; Xia X; Song W
    Front Oncol; 2021; 11():619003. PubMed ID: 33767987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. System analysis of
    Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
    Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression and methylation profiles identified CXCL3 and CXCL8 as key genes for diagnosis and prognosis of colon adenocarcinoma.
    Zhao QQ; Jiang C; Gao Q; Zhang YY; Wang G; Chen XP; Wu SB; Tang J
    J Cell Physiol; 2020 May; 235(5):4902-4912. PubMed ID: 31709538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated multiplex network based approach reveled CC and CXC chemokines associated key biomarkers in colon adenocarcinoma patients.
    Huang W; Hu Y; Zhang X; Xu Y; Sun Z; Ding P; Qian X; Ali A; Chen Z
    Am J Cancer Res; 2023; 13(11):5531-5548. PubMed ID: 38058831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors-A Review of Literature.
    Korbecki J; Kojder K; Kapczuk P; Kupnicka P; Gawrońska-Szklarz B; Gutowska I; Chlubek D; Baranowska-Bosiacka I
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Therapeutic Targets and Prognostic Biomarkers Among CXC Chemokines in the Renal Cell Carcinoma Microenvironment.
    Zeng Q; Sun S; Li Y; Li X; Li Z; Liang H
    Front Oncol; 2019; 9():1555. PubMed ID: 32117786
    [No Abstract]   [Full Text] [Related]  

  • 14. CXC chemokines located in the 4q21 region are up-regulated in breast cancer.
    Bièche I; Chavey C; Andrieu C; Busson M; Vacher S; Le Corre L; Guinebretière JM; Burlinchon S; Lidereau R; Lazennec G
    Endocr Relat Cancer; 2007 Dec; 14(4):1039-52. PubMed ID: 18045955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic analysis of the BET family in adrenocortical carcinoma: The expression, prognosis, gene regulation network, and regulation targets.
    Situ Y; Liang Q; Zeng Z; Chen J; Shao Z; Xu Q; Lu X; Cui Y; Zhang J; Lu L; Deng L
    Front Endocrinol (Lausanne); 2023; 14():1089531. PubMed ID: 36793283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression levels of chemokine (C-X-C motif) ligands CXCL1 and CXCL3 as prognostic biomarkers in rectal adenocarcinoma: evidence from Gene Expression Omnibus (GEO) analyses.
    Lv QY; Zou HZ; Xu YY; Shao ZY; Wu RQ; Li KJ; Deng X; Gu DN; Jiang HX; Su M; Zou CL
    Bioengineered; 2021 Dec; 12(1):3711-3725. PubMed ID: 34269159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of the prognosis and immune infiltration for CXC chemokines in colorectal cancer.
    Yang X; Wei Y; Sheng F; Xu Y; Liu J; Gao L; Yang J; Sun X; Huang J; Guo Q
    Aging (Albany NY); 2021 Jul; 13(13):17548-17567. PubMed ID: 34233297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the Prognostic Value and Clinical Significance of Interferon Regulatory Factors (IRFs) in Colon Adenocarcinoma.
    Yuemaier M; Zhou Z; Zhou Y; Wu C; Li F; Liang X; Kang H; Shen D; Gao F; Lin J
    Med Sci Monit; 2020 Nov; 26():e927073. PubMed ID: 33161410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Significance and Therapeutic Target of CXC Chemokines in the Microenvironment of Lung Adenocarcinoma.
    Wang K; Li R; Zhang Y; Qi W; Fang T; Yue W; Tian H
    Int J Gen Med; 2022; 15():2283-2300. PubMed ID: 35250303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-Omics Reveal the Immunological Role and the Theragnostic Value of miR-216a/GDF15 Axis in Human Colon Adenocarcinoma.
    Tung CB; Li CY; Lin HY
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.